Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease
Min‐Tae Jeon, Kyu‐Sung Kim, Eun Seon Kim, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101333-101333
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

C-Reactive Protein as a Biomarker for Major Depressive Disorder?
Laura Orsolini, Simone Pompili, Silvia Tempia Valenta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1616-1616
Open Access | Times Cited: 82
Potential Biomarkers for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 602-602
Open Access | Times Cited: 69
Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 27
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 63
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation
María Fernanda Serna-Rodríguez, Sofía Bernal‐Vega, José Alfonso Ontiveros-Sánchez de la Barquera, et al.
Journal of Neuroimmunology (2022) Vol. 371, pp. 577951-577951
Closed Access | Times Cited: 58
In vivo methods for imaging blood–brain barrier function and dysfunction
William J. Harris, Marie‐Claude Asselin, Rainer Hinz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1051-1083
Open Access | Times Cited: 39
Neuroinflammation and peripheral immunity: Focus on ischemic stroke
Huiqing Wang, Shenyang Zhang, Lili Xie, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110332-110332
Closed Access | Times Cited: 37
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 15
Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood–Brain Barrier
Sinnead Anne Cogill, Jae-Hyeok Lee, Min‐Tae Jeon, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 789-789
Open Access | Times Cited: 8
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice
Daozhou Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery
Axel H. Meyer, Thomas M. Feldsien, Mario Mezler, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1100-1100
Open Access | Times Cited: 15
Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation
Ian Galea, Soham Bandyopadhyay, Diederik Bulters, et al.
Stroke (2023) Vol. 54, Iss. 7, pp. 1930-1942
Open Access | Times Cited: 15
Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases
Rohan Gupta, Kumari Smita, Rahul Tripathi, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101855-101855
Closed Access | Times Cited: 14
Infiltrating peripheral monocyte TREM-1 mediates dopaminergic neuron injury in substantia nigra of Parkinson’s disease model mice
Weihong Song, Zi-ming Zhou, Lele Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
Tingting Wen, Zhaohui Zhang
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Alterations in the inflammatory homeostasis of aging‐related cardiac dysfunction and Alzheimer's diseases
Siyuan Huang, Jeremiah Nunez, Dai Lan Toresco, et al.
The FASEB Journal (2025) Vol. 39, Iss. 1
Closed Access
Modulation of Intestinal Inflammation and Protection of Dopaminergic Neurons in Parkinson’s Disease Mice through a Probiotic Formulation Targeting NLRP3 Inflammasome
Liping Zhou, Ka Ying Wong, Hongxiang Xie
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid-β aggregation and inhibiting fungal infection
Chaoren Yan, Chaoli Wang, Xu Shao, et al.
Materials Today Bio (2021) Vol. 12, pp. 100167-100167
Open Access | Times Cited: 26
Piceatannol Protects Brain Endothelial Cell Line (bEnd.3) against Lipopolysaccharide-Induced Inflammation and Oxidative Stress
Yan Zhou, Haroon Khan, Maggie Pui Man Hoi, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 18
The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells
Hamdam Hourfar, Farhang Aliakbari, Shabboo Rahimi Aqdam, et al.
International Journal of Biological Macromolecules (2022) Vol. 229, pp. 305-320
Open Access | Times Cited: 18
Eveningness chronotype and depressive affective temperament associated with higher high-sensitivity C-reactive protein in unipolar and bipolar depression
Laura Orsolini, Leonardo Ricci, Simone Pompili, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 210-220
Open Access | Times Cited: 10
Glial Cultures Differentiated from iPSCs of Patients with PARK2-Associated Parkinson’s Disease Demonstrate a Pro-Inflammatory Shift and Reduced Response to TNFα Stimulation
Tatiana Gerasimova, Ekaterina Stepanenko, Lyudmila Novosadova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2000-2000
Open Access | Times Cited: 9
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease
Jasna Šaponjić, Rebeca Mejı́as, Neda Nikolovski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4330-4330
Open Access | Times Cited: 3
The Impact of the Blood–Brain Barrier and Its Dysfunction in Parkinson’s Disease: Contributions to Pathogenesis and Progression
Muhammad Khalid Iqbal, Bakhtawar Khan, Hifsa Hifsa, et al.
ACS Omega (2024) Vol. 9, Iss. 46, pp. 45663-45672
Open Access | Times Cited: 3
Infant nutrition affects the microbiota-gut-brain axis: Comparison of human milk vs. infant formula feeding in the piglet model
Elise Charton, Alexandre Bourgeois, Amandine Bellanger, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top